Kymera Therapeutics, Inc. (KYMR)
87.40
+0.90
(+1.04%)
USD |
NASDAQ |
Feb 20, 16:00
88.88
+1.48
(+1.69%)
Pre-Market: 20:00
Kymera Therapeutics Market Cap : 6.288B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Gilead Sciences, Inc. | 187.84B |
| Eli Lilly & Co. | 952.34B |
| Cytokinetics, Inc. | 8.307B |
| Travere Therapeutics, Inc. | 2.719B |
Market Cap Related Metrics
| PS Ratio | 163.81 |
| PEG Ratio | -0.4461 |
| Price to Book Value | 6.646 |
| Price | 87.40 |
| Earnings Yield | -4.11% |
| PEGY Ratio | -0.4461 |